These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 24319168)

  • 1. Management of the refractory aplastic anemia patient: what are the options?
    Marsh JC; Kulasekararaj AG
    Hematology Am Soc Hematol Educ Program; 2013; 2013():87-94. PubMed ID: 24319168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of the refractory aplastic anemia patient: what are the options?
    Marsh JC; Kulasekararaj AG
    Blood; 2013 Nov; 122(22):3561-7. PubMed ID: 24052548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eltrombopag for the treatment of aplastic anemia: current perspectives.
    Lum SH; Grainger JD
    Drug Des Devel Ther; 2016; 10():2833-2843. PubMed ID: 27695288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
    Peffault de Latour R; Kulasekararaj A; Iacobelli S; Terwel SR; Cook R; Griffin M; Halkes CJM; Recher C; Barraco F; Forcade E; Vallejo JC; Drexler B; Mear JB; Smith AE; Angelucci E; Raymakers RAP; de Groot MR; Daguindau E; Nur E; Barcellini W; Russell NH; Terriou L; Iori AP; La Rocca U; Sureda A; Sánchez-Ortega I; Xicoy B; Jarque I; Cavenagh J; Sicre de Fontbrune F; Marotta S; Munir T; Tjon JML; Tavitian S; Praire A; Clement L; Rabian F; Marano L; Hill A; Palmisani E; Muus P; Cacace F; Frieri C; van Lint MT; Passweg JR; Marsh JCW; Socié G; Mufti GJ; Dufour C; Risitano AM;
    N Engl J Med; 2022 Jan; 386(1):11-23. PubMed ID: 34986284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of aplastic anemia after failure of frontline immunosuppression.
    Pierri F; Dufour C
    Expert Rev Hematol; 2019 Oct; 12(10):809-819. PubMed ID: 31311355
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia: Are Patients Cured?
    Scheinberg P
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):609-618. PubMed ID: 30047414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Treatment of Aplastic Anemia.
    Peslak SA; Olson T; Babushok DV
    Curr Treat Options Oncol; 2017 Nov; 18(12):70. PubMed ID: 29143887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
    Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
    Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
    Martynova A; Chiu V; Mert M; Hermel D; Weitz IC
    Ann Hematol; 2021 Apr; 100(4):933-939. PubMed ID: 33420879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutic choices in immune aplastic anemia.
    Scheinberg P
    F1000Res; 2020; 9():. PubMed ID: 32953089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP).
    Barone A; Lucarelli A; Onofrillo D; Verzegnassi F; Bonanomi S; Cesaro S; Fioredda F; Iori AP; Ladogana S; Locasciulli A; Longoni D; Lanciotti M; Macaluso A; Mandaglio R; Marra N; Martire B; Maruzzi M; Menna G; Notarangelo LD; Palazzi G; Pillon M; Ramenghi U; Russo G; Svahn J; Timeus F; Tucci F; Cugno C; Zecca M; Farruggia P; Dufour C; Saracco P;
    Blood Cells Mol Dis; 2015 Jun; 55(1):40-7. PubMed ID: 25976466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
    Townsley DM; Scheinberg P; Winkler T; Desmond R; Dumitriu B; Rios O; Weinstein B; Valdez J; Lotter J; Feng X; Desierto M; Leuva H; Bevans M; Wu C; Larochelle A; Calvo KR; Dunbar CE; Young NS
    N Engl J Med; 2017 Apr; 376(16):1540-1550. PubMed ID: 28423296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aplastic anemia: therapeutic updates in immunosuppression and transplantation.
    Scheinberg P
    Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in drug therapy for aplastic anemia.
    Willis L; Rexwinkle A; Bryan J; Kadia TM
    Ann Pharmacother; 2014 Nov; 48(11):1469-78. PubMed ID: 25184310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children.
    Jie M; Fu L; Li S; He Y; Yao J; Cheng X; Zhang L; Zheng J; Zhang R; Wu R
    Pediatr Hematol Oncol; 2021 Oct; 38(7):647-657. PubMed ID: 33798022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?
    Huang LF; Li L; Jia JS; Yang Y; Lin SY; Meng FK; Zhang DH; He GS
    Transplant Cell Ther; 2022 Sep; 28(9):586.e1-586.e7. PubMed ID: 35609866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
    Marotta S; Pagliuca S; Risitano AM
    Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.
    Assi R; Garcia-Manero G; Ravandi F; Borthakur G; Daver NG; Jabbour E; Burger J; Estrov Z; Dinardo CD; Alvarado Y; Hendrickson S; Ferrajoli A; Wierda W; Cortes J; Kantarjian H; Kadia TM
    Cancer; 2018 Nov; 124(21):4192-4201. PubMed ID: 30307606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.
    Suzuki K; Muramatsu H; Okuno Y; Narita A; Hama A; Takahashi Y; Yoshida M; Horikoshi Y; Watanabe K; Kudo K; Kojima S
    Int J Hematol; 2016 Jul; 104(1):130-3. PubMed ID: 27107757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.